Alcohol Addiction: Neurobiology, Progression, and Treatment Pathways

Alcohol use disorder (AUD) is a chronic, relapsing brain disorder characterized by impaired control over drinking, preoccupation with alcohol, and continued use despite adverse consequences. It arises from a complex interplay of genetic, neurobiological, psychological, and environmental factors.

Neurobiological Stages

  1. Binge/Intoxication: Alcohol → ↑ dopamine in nucleus accumbens (reward) + ↑ GABA (inhibition) + ↓ glutamate (excitation) → euphoria, sedation.
  2. Withdrawal/Negative Affect: Chronic use → neuroadaptation (↓ GABA receptors, ↑ NMDA receptors). Abstinence → hyperexcitability: anxiety, tremor, insomnia, seizures, dysphoria. Drinking relieves this → negative reinforcement.
  3. Preoccupation/Anticipation (Craving): Prefrontal cortex dysregulation → impaired executive control, heightened stress reactivity, cue-induced craving (amygdala, hippocampus).

Key Risk Factors

  • Genetics: Heritability ~50–60%; genes affecting alcohol metabolism (ADH, ALDH), dopamine/opioid signaling (DRD2, OPRM1), stress response (CRH, GABRA2).
  • Early onset: Drinking <15 years → 4× higher AUD risk.
  • Trauma/ACEs: Childhood adversity, PTSD.
  • Comorbid mental illness: Depression, anxiety, bipolar—self-medication cycle.
  • Social/environmental: Peer norms, availability, stress, marketing.

Evidence-Based Treatments

  • Medications (FDA-approved): Naltrexone (craving/heavy drinking), acamprosate (abstinence maintenance), disulfiram (aversion).
  • Behavioral: CBT, motivational interviewing (MI), contingency management, 12-step facilitation, mindfulness-based relapse prevention.
  • Levels of care: Outpatient → intensive outpatient (IOP) → partial hospitalization (PHP) → residential → medically managed detox (for severe withdrawal risk).
  • Mutual support: AA, SMART Recovery, LifeRing, Women for Sobriety.

Recovery is non-linear; remission is achievable with sustained, multimodal care.

Drug Addiction - Related Articles